TAVI: FDA OKs Direct Flow Medical's U.S. pivotal trial for heart valve

The FDA gives the go-ahead to Direct Flow Medical for a U.S. pivotal trial of its transcatheter aortic valve implant.

Direct Flow Medical said the FDA granted an investigational device exemption for a U.S. pivotal trial for its transcatheter aortic valve implant.

Direct Flow Medical Inc.

News Well, Clinical Trials, Replacement Heart Valves

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/SjqiOn